2.35 USD
↘ 0.04 (1.71%)PRE MARKET (AS OF 04:01 AM EDT)
Context Therapeutics Inc. Common Stock
CNTXNASDAQ • USD
Market: OPEN
Open?$2.29
High?$2.30
Low?$2.29
Prev. Close?$2.34
Volume?N/A
Avg. Volume?901.2K
Bid / Ask
Bid?$2.00 × 100
Ask?$2.72 × 100
Spread?$0.72
Midpoint?$2.36
Valuation & Ratios
Market Cap?215.0M
Shares Out?91.9M
Float?67.5M
Float %?73.5%
P/E Ratio?N/A
P/B Ratio?3.56
EPS?-$0.39
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.52Strong
Quick Ratio?8.52Strong
Cash Ratio?8.23Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?3.56FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.8CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-59.7%WEAK▾
ROA?-52.7%WEAK▾
Cash Flow & Enterprise
FCF?$-26419328
Enterprise Value?$149.0M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Employees
15
Market Cap
207.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-20
Address
2001 MARKET STREET
PHILADELPHIA, PA 19103
Phone: 267-225-7416
PHILADELPHIA, PA 19103
Phone: 267-225-7416